Updated prevalence, predictors and treatment outcomes for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation

Bronchiolitis obliterans syndrome (BOS) after allogeneic haemopoietic stem cell transplant (HSCT) is an under-recognised and difficult to treat disease. This occurs in the context of limited clinical research and inconsistent diagnostic criteria.

Source: Respiratory Medicine - December 23, 2020 Category: Respiratory Medicine Authors: Jonathan Pham, Jhanavi Rangaswamy, Sharon Avery, Brigitte Borg, Catherine Martin, Maitri Munsif, Tiffany Lin, Eli Dabscheck Source Type: research